Literature DB >> 10084311

Influence of increased c-Myc expression on the growth characteristics of human melanoma.

H Schlagbauer-Wadl1, M Griffioen, A van Elsas, P I Schrier, T Pustelnik, H G Eichler, K Wolff, H Pehamberger, B Jansen.   

Abstract

Overexpression of the proto-oncogene c-myc has been associated with neoplastic transformation in a variety of tumors. For human melanoma high c-myc expression has been found in the vertical growth phase and higher positivity reported in metastases than primary tumors. The principle aim of this study was to determine, whether c-Myc expression influences the metastatic behavior of human melanoma in the absence of lymphocyte-mediated immune phenomena. The growth characteristics and tumor biology of two c-myc transfectants of the human melanoma cell line IGR39D, expressing c-Myc 1.7 and three times over baseline and the respective vector control were analyzed both in vitro and in a severe combined immunodeficient mouse model in vivo. Both c-myc transfectants showed increased growth rates, anchorage independent growth and directed cell movement in culture. Subcutaneously implanted IGR39D melanomas highly overexpressing c-Myc spontaneously formed macroscopic metastases (lymph nodes and lung) in severe combined immunodeficient mice in all cases (n = 7 per group), whereas less prominent c-Myc overexpression caused the development of only lung micrometastases. During the time period leading to terminal disease in animals injected with c-myc transfected human melanoma cells, melanoma development was not seen in vector controls. These findings suggest that constitutive high c-Myc expression in human melanoma results in a more aggressive growth behavior both in vitro and in vivo and favors metastasis in severe combined immunodeficient mice by factors unrelated to immune phenomena such as class I human leukocyte antigen downregulation known to be associated with c-Myc expression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10084311     DOI: 10.1046/j.1523-1747.1999.00506.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  18 in total

1.  Genetic and Environmental Determinants of Immune Response to Cutaneous Melanoma.

Authors:  Joanna Poźniak; Jérémie Nsengimana; Jonathan P Laye; Sally J O'Shea; Joey Mark S Diaz; Alastair P Droop; Anastasia Filia; Mark Harland; John R Davies; Tracey Mell; Juliette A Randerson-Moor; Sathya Muralidhar; Sabrina A Hogan; Sandra Nicole Freiberger; Mitchell P Levesque; Graham P Cook; D Timothy Bishop; Julia Newton-Bishop
Journal:  Cancer Res       Date:  2019-02-17       Impact factor: 12.701

Review 2.  Molecular aspects of melanocytic dysplastic nevi.

Authors:  Mahmoud Rezk Abd-Elwahed Hussein; Gary Stewart Wood
Journal:  J Mol Diagn       Date:  2002-05       Impact factor: 5.568

3.  A signal transduction pathway from TGF-β1 to SKP2 via Akt1 and c-Myc and its correlation with progression in human melanoma.

Authors:  Xuan Qu; Liangliang Shen; Yan Zheng; Yang Cui; Zhihui Feng; Feng Liu; Jiankang Liu
Journal:  J Invest Dermatol       Date:  2013-06-21       Impact factor: 8.551

Review 4.  Structural insights into G-quadruplexes: towards new anticancer drugs.

Authors:  Danzhou Yang; Keika Okamoto
Journal:  Future Med Chem       Date:  2010-04       Impact factor: 3.808

5.  Acridine-modified, clamp-forming antisense oligonucleotides synergize with cisplatin to inhibit c-Myc expression and B16-F0 tumor progression.

Authors:  Delisha A Stewart; Xiaohua Xu; Shelia D Thomas; Donald M Miller; Xiaohou Xu
Journal:  Nucleic Acids Res       Date:  2002-06-01       Impact factor: 16.971

6.  Thermodynamic stability and folding kinetics of the major G-quadruplex and its loop isomers formed in the nuclease hypersensitive element in the human c-Myc promoter: effect of loops and flanking segments on the stability of parallel-stranded intramolecular G-quadruplexes.

Authors:  Emmanuel Hatzakis; Keika Okamoto; Danzhou Yang
Journal:  Biochemistry       Date:  2010-11-02       Impact factor: 3.162

7.  A strategy for combating melanoma with oncogenic c-Myc inhibitors and targeted nanotherapy.

Authors:  Dipanjan Pan; Benjamin Kim; Grace Hu; Deepti Sood Gupta; Angana Senpan; Xiaoxia Yang; Anne Schmieder; Corban Swain; Samuel A Wickline; Michael H Tomasson; Gregory M Lanza
Journal:  Nanomedicine (Lond)       Date:  2015-01       Impact factor: 5.307

8.  Structural recognition of the MYC promoter G-quadruplex by a quinoline derivative: insights into molecular targeting of parallel G-quadruplexes.

Authors:  Jonathan Dickerhoff; Jixun Dai; Danzhou Yang
Journal:  Nucleic Acids Res       Date:  2021-06-04       Impact factor: 16.971

9.  I-motif structures formed in the human c-MYC promoter are highly dynamic--insights into sequence redundancy and I-motif stability.

Authors:  Jixun Dai; Emmanuel Hatzakis; Laurence H Hurley; Danzhou Yang
Journal:  PLoS One       Date:  2010-07-19       Impact factor: 3.240

10.  c-MYC promoter G-quadruplex formed at the 5'-end of NHE III1 element: insights into biological relevance and parallel-stranded G-quadruplex stability.

Authors:  Raveendra I Mathad; Emmanuel Hatzakis; Jixun Dai; Danzhou Yang
Journal:  Nucleic Acids Res       Date:  2011-07-27       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.